Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.26
Delayed Data
As of 9:52am ET
 +0.0101 / +0.45%
Today’s Change
1.69
Today|||52-Week Range
6.69
-12.40%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.25
Today’s open2.26
Day’s range2.26 - 2.42
Volume2,255
Average volume (3 months)973,087
Market cap$53.9M
Dividend yield--
Data as of 9:52am ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+56.50%
Earnings growth (this year)+18.56%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+77.69%
P/E ratioNM
Price/Sales1.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AVIRAviragen Therapeutic...0.000.00%
TNXPTonix Pharmaceutical...+0.03+1.51%
XOMAXOMA Corp+0.01+0.96%
RNNRexahn Pharmaceutica...+0.01+3.42%
Data as of 10:25am ET, 07/01/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$51.2M
Annual profit (last year)-$16.3M
Net profit margin-31.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs